Skip to content
  • Home
  • World News
  • Business
  • Aviation
  • Military
  • Lifestyle
  • Real Estate
  • Auto
195 news

195News

All the news that's fit to print

  • Home
  • World News
  • Business
  • Aviation
  • Military
  • Lifestyle
  • Real Estate
  • Auto
  • Toggle search form
  • 4 Ways to Get Free Money in 2022 Lifestyle
  • The electric aviation market is buzzing Aviation
  • Empowering Projects and Teams, PPM Express Now Integrates Monday.com World News
  • Northwestern Mutual: 3 Questions to Ask When Negotiating a Job Offer Lifestyle
  • Harley-Davidson’s Serial 1 Introduces The BASH/MTN Electric Mountain Bike Aviation
  • Zelenskiy receives standing ovation after EU parliament speech World News
  • 3rd International Hydrogen Aviation Conference (IHAC 2022), 1st September 2022, Glasgow: Agenda Released Energy
  • Can AI smart glasses make blind people more independent? – BBC News World News

Nemysis Ltd and Faran S.A. Sign a Strategic Agreement to Cooperate for the Development of Endopeptidase E40 for Celiac Disease

Posted on December 2, 2022 By NewsEditor
Nemysis Ltd and Faran S.A. Sign a Strategic Agreement to Cooperate for the Development of Endopeptidase E40 for Celiac DiseaseDUBLIN - December 2, 2022 - (Newswire.com)

Nemysis Ltd today announces a Strategic Cooperation with Faran S.A., a leading Greek pharma company, for the development and later commercialization of its E40 endopeptidase as a novel enzymatic therapy for gluten degradation.

"Faran has a longstanding tradition in bringing to the Greek market innovative products and providing innovative solutions to tackle highly prevalent unmet medical conditions. The company has established over the years several strategic partnerships with established pharma companies from all over the world," said Danilo Casadei Massari, Nemysis's Chairman, and CEO. "We are pleased to cooperate in the late-stage development of E40, a novel enzymatic therapy for gluten degradation which will bring relief to the many patients suffering from symptoms of Celiac Disease. Faran will also be instrumental in defining the most effective route to the market for our product, which is expected to be on the market in late 2024."

Mr. Katsikas, President & CEO of Faran, commented on the agreement "expressing satisfaction for the new cooperation agreement which is further recognition of the key role of the company in the Greek market, spanning over 70 years of successful tradition. E40 will perfectly fit in our portfolio and complement our presence in the specific field."

About Faran:

FARAN S.A. is one of the most historic pharmaceutical companies in Greece, founded in 1950, and aims to offer renowned therapeutic proposals of high quality, therapeutic value, modern pharmaceutical technology, and documented safety.

With selected international collaborations and the trust of the medical community, it offers therapeutic solutions to a wide range of diseases in the field of Oncology, Hematology, Nephrology, Rheumatology, Orthopedics, Dermatology, Gastroenterology, Endocrinology, Pathology and Gynecology and, from Autumn 2022, also in Cardiology.

About Nemysis:

NEMYSIS LTD, a healthcare and pharmaceutical company, is focused on nutritional and pharmaceutical solutions that can protect against some of the negative consequences of nutrient deficiency, nutrient intolerances, and sensitivities, paying particular attention to the need to safeguard the human microbiome.

Nemysis's novel nanoparticulate iron is the first natural ferritin mimic, which can correct human iron deficiency and anemia, without negatively impacting the gut microbiome. Safety and efficacy have been demonstrated in controlled-repeat-dose clinical trials.

Nemysis's novel E40 endopeptidase is gastric, trypsin, and chymotrypsin resistant. It has been shown to destroy all the immuno-stimulatory epitopes of gluten, quenching the exacerbated inflammatory response of primed, gluten-sensitive, and hyper-responsive human T cells. It is, therefore, suitable for the enzymatic management of gluten intolerance and sensitivity.

www.nemysisltd.com

Danilo Casadei-Massari

Suite 4.01 Ormond Building

31-36 Ormond Quay Upper

Arran Quay D07 F6DC - Ireland +35315313450

[email protected]


Contact Information:
Danilo Casadei Massari
CEO
[email protected]
+35315313450


Press Release Service by Newswire.com

Original Source: Nemysis Ltd and Faran S.A. Sign a Strategic Agreement to Cooperate for the Development of Endopeptidase E40 for Celiac Disease
Business

Post navigation

Previous Post: War Day 41 :: war chronicles with Advisor to Ukraine President, Intel Officer, Alexey Arestovych
Next Post: Ritani to Co-Host Holiday Gift Shop in East Village New York City

Related Posts

  • Mokaram Law Firm Gives Back to Houston Families at First Annual Thanksgiving Event: 1,000 Frozen Turkeys to Be Given Away Nov. 18 at 2500 West Loop South, Houston, Texas 77027 Business
  • Green Tires Global Market To Grow At Rate Of 11% Through 2026 Business
  • Consumers Receive Compensation From Dealerships for Illegal Charges and Fees for Lease Buyouts Business
  • Volition Beauty and A+E Networks Unveil Product Development Partnership Business
  • Dolman Law Group Currently Accepting Hair Relaxer-Uterine Cancer Cases Business
  • Campendium Introduces New Android App Business
January 2023
MTWTFSS
 1
2345678
9101112131415
16171819202122
23242526272829
3031 
« Dec    
last celebrity gossip
Gossip Stone - celebrity life and gossip

Recent Posts

  • Sanctioning Senior Paraguayan Officials for CorruptionJanuary 28, 2023
  • War Day 337: war diaries w/Former Advisor to Ukraine President, Intel Officer @arestovych & #FeyginJanuary 28, 2023
  • James bond says goodbye to the cast(lifestories.goalcast)January 28, 2023
  • Secretary Blinken’s Travel to Egypt, Israel, and the West BankJanuary 28, 2023
  • 8 New Lincoln Cars and SUVs Shaping the Brand’s Future Strategy (Overview of 2022 News)January 28, 2023
how to promote press release
VUGA Enterprises - media group PR & Marketing
  • U.S. Polo Assn. Welcomes the XII Federation of International Polo (FIP) World Polo Championship to Palm Beach County, Florida Lifestyle
  • The Fed Just Crashed the Market Real Estate
  • War Day 257: war diaries w/Advisor to Ukraine President, Intel Officer @Alexey Arestovych & #Feygin World News
  • State of Emergency l WNT Aviation
  • Global Interventional Neurology Devices and Equipment Market Trends, Strategies, Opportunities For 2022-2031 World News
  • Atlanta Based Specialty Realty Group Reorganizes, Changes Business Plan & Leadership Real Estate
  • 10 Supercars that Got Custom Designs and Crazy Engine Upgrades Auto
  • Credello: Why You Must Know About the Rule of 72 When It Comes to Inflation and Your Savings Lifestyle
aerospace company
stem cell clinic in kiev
medical spa in miami
Fashion TV free

Copyright © 2023 195News.

| Part of VUGA Media Group | Fair Use | Terms of Use | Get Published